These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9268373)
1. Protein-protein interaction specificity of Im9 for the endonuclease toxin colicin E9 defined by homologue-scanning mutagenesis. Li W; Dennis CA; Moore GR; James R; Kleanthous C J Biol Chem; 1997 Aug; 272(35):22253-8. PubMed ID: 9268373 [TBL] [Abstract][Full Text] [Related]
2. Dual recognition and the role of specificity-determining residues in colicin E9 DNase-immunity protein interactions. Li W; Hamill SJ; Hemmings AM; Moore GR; James R; Kleanthous C Biochemistry; 1998 Aug; 37(34):11771-9. PubMed ID: 9718299 [TBL] [Abstract][Full Text] [Related]
3. Specificity in protein-protein recognition: conserved Im9 residues are the major determinants of stability in the colicin E9 DNase-Im9 complex. Wallis R; Leung KY; Osborne MJ; James R; Moore GR; Kleanthous C Biochemistry; 1998 Jan; 37(2):476-85. PubMed ID: 9425068 [TBL] [Abstract][Full Text] [Related]
4. Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 2. Cognate and noncognate interactions that span the millimolar to femtomolar affinity range. Wallis R; Leung KY; Pommer AJ; Videler H; Moore GR; James R; Kleanthous C Biochemistry; 1995 Oct; 34(42):13751-9. PubMed ID: 7577967 [TBL] [Abstract][Full Text] [Related]
5. Highly discriminating protein-protein interaction specificities in the context of a conserved binding energy hotspot. Li W; Keeble AH; Giffard C; James R; Moore GR; Kleanthous C J Mol Biol; 2004 Mar; 337(3):743-59. PubMed ID: 15019791 [TBL] [Abstract][Full Text] [Related]
6. Identification of critical residues in the colicin E9 DNase binding region of the Im9 protein. Osborne MJ; Wallis R; Leung KY; Williams G; Lian LY; James R; Kleanthous C; Moore GR Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):823-31. PubMed ID: 9169618 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the protein-protein interaction between the E9 immunity protein and colicin E9. Wallis R; Moore GR; Kleanthous C; James R Eur J Biochem; 1992 Dec; 210(3):923-30. PubMed ID: 1483475 [TBL] [Abstract][Full Text] [Related]
8. Specificity in protein-protein interactions: the structural basis for dual recognition in endonuclease colicin-immunity protein complexes. Kühlmann UC; Pommer AJ; Moore GR; James R; Kleanthous C J Mol Biol; 2000 Sep; 301(5):1163-78. PubMed ID: 10966813 [TBL] [Abstract][Full Text] [Related]
9. Experimental and computational analyses of the energetic basis for dual recognition of immunity proteins by colicin endonucleases. Keeble AH; Joachimiak LA; Maté MJ; Meenan N; Kirkpatrick N; Baker D; Kleanthous C J Mol Biol; 2008 Jun; 379(4):745-59. PubMed ID: 18471830 [TBL] [Abstract][Full Text] [Related]
10. Identification of putative active-site residues in the DNase domain of colicin E9 by random mutagenesis. Garinot-Schneider C; Pommer AJ; Moore GR; Kleanthous C; James R J Mol Biol; 1996 Aug; 260(5):731-42. PubMed ID: 8709151 [TBL] [Abstract][Full Text] [Related]
11. Identification of residues in the putative TolA box which are essential for the toxicity of the endonuclease toxin colicin E9. -Schneider CG; Penfold CN; Moore GR; Kleanthous C; James R Microbiology (Reading); 1997 Sep; 143 ( Pt 9)():2931-2938. PubMed ID: 9308177 [TBL] [Abstract][Full Text] [Related]
12. Calorimetric dissection of colicin DNase--immunity protein complex specificity. Keeble AH; Kirkpatrick N; Shimizu S; Kleanthous C Biochemistry; 2006 Mar; 45(10):3243-54. PubMed ID: 16519519 [TBL] [Abstract][Full Text] [Related]
13. Tandem overproduction and characterisation of the nuclease domain of colicin E9 and its cognate inhibitor protein Im9. Wallis R; Reilly A; Barnes K; Abell C; Campbell DG; Moore GR; James R; Kleanthous C Eur J Biochem; 1994 Mar; 220(2):447-54. PubMed ID: 8125102 [TBL] [Abstract][Full Text] [Related]
14. Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 1. Diffusion-controlled association and femtomolar binding for the cognate complex. Wallis R; Moore GR; James R; Kleanthous C Biochemistry; 1995 Oct; 34(42):13743-50. PubMed ID: 7577966 [TBL] [Abstract][Full Text] [Related]
15. NMR investigation of the interaction of the inhibitor protein Im9 with its partner DNase. Boetzel R; Czisch M; Kaptein R; Hemmings AM; James R; Kleanthous C; Moore GR Protein Sci; 2000 Sep; 9(9):1709-18. PubMed ID: 11045617 [TBL] [Abstract][Full Text] [Related]
16. Using chimeric immunity proteins to explore the energy landscape for alpha-helical protein folding. Ferguson N; Li W; Capaldi AP; Kleanthous C; Radford SE J Mol Biol; 2001 Mar; 307(1):393-405. PubMed ID: 11243827 [TBL] [Abstract][Full Text] [Related]
17. Three-dimensional solution structure and 13C nuclear magnetic resonance assignments of the colicin E9 immunity protein Im9. Osborne MJ; Breeze AL; Lian LY; Reilly A; James R; Kleanthous C; Moore GR Biochemistry; 1996 Jul; 35(29):9505-12. PubMed ID: 8755730 [TBL] [Abstract][Full Text] [Related]
18. NMR detection of slow conformational dynamics in an endonuclease toxin. Whittaker SB; Boetzel R; MacDonald C; Lian LY; Pommer AJ; Reilly A; James R; Kleanthous C; Moore GR J Biomol NMR; 1998 Jul; 12(1):145-59. PubMed ID: 9729794 [TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro characterization of overproduced colicin E9 immunity protein. Wallis R; Reilly A; Rowe A; Moore GR; James R; Kleanthous C Eur J Biochem; 1992 Jul; 207(2):687-95. PubMed ID: 1633820 [TBL] [Abstract][Full Text] [Related]
20. Characterisation of a mobile protein-binding epitope in the translocation domain of colicin E9. Macdonald CJ; Tozawa K; Collins ES; Penfold CN; James R; Kleanthous C; Clayden NJ; Moore GR J Biomol NMR; 2004 Sep; 30(1):81-96. PubMed ID: 15452437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]